文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

聚焦治疗限制与DNACPR决策:COVID-19如何改变了实践

Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice.
PubMed 文献 · Resuscitation · 2020-08-20
一句话结论COVID-19疫情期间DNACPR/TEAL表单填写量明显增加,更多患者被判定适合CPR和全力治疗,但与家属的讨论比例下降。

该研究基于英国一家大型教学医院的电子病历系统,收集2017年1月1日至2020年4月30日所有DNACPR/TEAL状态表单,比较疫情2个月高峰阶段与2019年同期决策模式和表单完成率。共完成16,007份表单,疫情期间填写量明显增加,完成表单的患者平均更年轻、合并症更少。多个表单问题回答显著不同:被判定适合CPR者增加(23.8% vs 9.05%,p<0.001),适合全力治疗者增加(30.5% vs 26.1%,p=0.028);涉及患者的讨论比例相近(95.8% vs 95.6%,p=0.871),但与家属的讨论减少(50.6% vs 75.4%,p<0.001)。作者认为疫情期间对高级决策和治疗上限讨论的重视似乎改变了实践,但尚不清楚疫情缓解后这些态度变化是否持续。

要点

  • 疫情期间DNACPR/TEAL表单完成量较2019年同期明显增加,完成表单者平均更年轻、合并症更少。
  • 被判定适合CPR的患者比例从9.05%升至23.8%(p<0.001),适合全力治疗者从26.1%升至30.5%(p=0.028)。
  • 涉及患者的讨论比例疫情期与2019年同期相近(95.8% vs 95.6%,p=0.871)。
  • 与家属的讨论比例从75.4%降至50.6%(p<0.001)。
  • 作者认为疫情期间对高级决策和治疗上限讨论的重视似乎改变了实践,但是否持续尚不清楚。

适用人群与场景

  • 英国一家大型教学医院中所有填写DNACPR/TEAL状态表单的患者,数据收集时间为2017年1月1日至2020年4月30日。
  • 比较对象为2个月疫情高峰阶段与2019年同期(3–4月)填写表单的患者。

研究设计与关键结果

  • 研究类型为基于电子病历的DNACPR/TEAL表单回顾性分析,共完成16,007份表单,数据来自英国一家大型教学医院。
  • 疫情期间表单完成量明显增加,完成表单的患者平均更年轻且合并症更少(与2019年3–4月相比)。
  • 被判定适合CPR的患者比例疫情期为23.8%,2019年同期为9.05%(p<0.001)。
  • 被判定适合全力治疗的患者比例疫情期为30.5%,2019年同期为26.1%(p=0.028)。
  • 涉及患者的讨论比例疫情期为95.8%,2019年同期为95.6%(p=0.871)。
  • 与家属的讨论比例疫情期为50.6%,2019年同期为75.4%(p<0.001)。

证据类型、等级与局限

  • 证据类型:基于电子病历的回顾性表单分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,疫情期间对高级决策和治疗上限讨论的重视似乎改变了实践,表现为更高比例的患者有DNACPR/TEAL状态记录。
  • 作者认为,理解患者对生命维持治疗与舒适治疗的偏好是整体实践的一部分,并支持共同决策。
  • 作者指出,尚不清楚这些态度变化在COVID-19入院减少后是否持续。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure complicates the benefit/harm balance of CPR.

METHODS: The study is based at a large teaching hospital in the United Kingdom where all DNACPR decisions are documented on an electronic healthcare record (EHR). Data from all DNACPR/TEAL status forms between 1st January 2017 and 30th April 2020 were collected and analysed. We compared patterns of decision making and rates of form completion during the 2-month peak pandemic phase to an analogous period during 2019.

RESULTS: A total of 16,007 forms were completed during the study period with a marked increase in form completion during the COVID-19 pandemic. Patients with a form completed were on average younger and had fewer co-morbidities during the COVID-19 period than in March-April 2019. Several questions on the DNACPR/TEAL forms were answered significantly differently with increases in patients being identified as suitable for CPR (23.8% versus 9.05%; p < 0.001) and full active treatment (30.5% versus 26.1%; p = 0.028). Whilst proportions of discussions that involved the patient remained similar during COVID-19 (95.8% versus 95.6%; p = 0.871), fewer discussions took place with relatives (50.6% versus 75.4%; p < 0.001).

CONCLUSION: During the COVID-19 pandemic, the emphasis on senior decision making and conversations around ceilings of treatment appears to have changed practice, with a higher proportion of patients having DNACPR/TEAL status documented. Understanding patient preferences around life-sustaining treatment versus comfort care is part of holistic practice and supports shared decision making. It is unclear whether these attitudinal changes will be sustained after COVID-19 admissions decrease.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Coleman JJ, Botkai A, Marson EJ, et al. Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice. Resuscitation. 2020. PMID: 32827587. doi:10.1016/j.resuscitation.2020.08.006

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。